Expert Review of Molecular Diagnostics

Tuberculosis diagnostics trials: do they lack methodological rigor?
pp. 509-514(6)
Authors: Pai, Madhukar; O'Brien, Richard

FIND and CEPHEID to develop rapid tuberculosis test for developing nations
pp. 515-517(3)

APTIMA^® transcription-mediated amplification assays for Chlamydia trachomatis and Neisseria gonorrhoeae
pp. 519-525(7)
Authors: Chernesky, Max A; Jang, Dan E

Screening for adverse reactions to irinotecan treatment using the Invader^® UGT1A1 Molecular Assay
pp. 527-533(7)
Authors: Hasegawa, Yoshinori; Ando, Yuichi; Shimokata, Kaoru

Microarray RNA transcriptional profiling: Part I. Platforms, experimental design and standardization
pp. 535-550(16)
Author: Ahmed, Farid E

Clinical applications of whole-genome association studies: future applications at the bedside
pp. 551-565(15)
Authors: Motsinger, Alison A; Ritchie, Marylyn D; Dobrin, Seth E

Multiplexed molecular detection using encoded microparticles and nanoparticles
pp. 567-574(8)
Authors: Li, Yougen; Luo, Dan

Metabolomic approaches to phenotype characterization and applications to complex diseases
pp. 575-585(11)
Authors: Orešič, Matej; Vidal-Puig, Antonio; Hänninen, Virve

Advances in Huntington's disease diagnostics: development of a standard reference material
pp. 587-596(10)
Authors: Levin, Barbara C; Richie, Kristy L; Jakupciak, John P

Current and future molecular diagnostics for prion diseases
pp. 597-611(15)
Authors: Lehto, Marty T; Peery, Harry E; Cashman, Neil R

Molecular pathways triggering glioma cell invasion
pp. 613-626(14)
Authors: Salhia, Bodour; Tran, Nhan L; Symons, Marc; Winkles, Jeffrey A; Rutka, James T; Berens, Michael E

Progress in biomarker discovery for diagnostic testing in epithelial ovarian cancer
pp. 627-637(11)
Authors: Gogoi, Radhika; Srinivasan, Shankar; Fishman, David A